APA (7th ed.) Citation

AA, Y., HA, I., MZ, O., EG, B., AA, E., A, H., . . . DB, I. (2018). Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality. Clinical and experimental gastroenterology, 11, 431. https://doi.org/10.2147/CEG.S171339

Chicago Style (17th ed.) Citation

AA, Youssef, Issa HA, Omar MZ, Behiry EG, Elfallah AA, Hasaneen A, Darwish M, and Ibrahim DB. "Serum Human Endothelial Cell-specific Molecule-1 (endocan) and Vascular Endothelial Growth Factor in Cirrhotic HCV Patients with Hepatocellular Carcinoma as Predictors of Mortality." Clinical and Experimental Gastroenterology 11 (2018): 431. https://doi.org/10.2147/CEG.S171339.

MLA (9th ed.) Citation

AA, Youssef, et al. "Serum Human Endothelial Cell-specific Molecule-1 (endocan) and Vascular Endothelial Growth Factor in Cirrhotic HCV Patients with Hepatocellular Carcinoma as Predictors of Mortality." Clinical and Experimental Gastroenterology, vol. 11, 2018, p. 431, https://doi.org/10.2147/CEG.S171339.